| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-23 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.32 | 8e-19 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-15 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-13 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-12 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-12 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |